Stock Notes

Star Health

Every Finvezto stock note on Star Health, dated and newest first. Coverage spans insurance.

2 notes and counting
28 Oct 2026
Star Health's Q2 profit rose 233% to Rs 265 crore from Rs 80 crore as insurance revenue grew 15% to Rs 5,074 crore.
Underwriting swung to a Rs 99 crore profit from a Rs 40 crore loss, so the core insurance book, not just investment income, carried the jump. It also redeemed all Rs 400 crore of its NCDs.
21 May 2026
Star Health targets ₹24,000 Cr in gross written premium for FY27 with 65% sourced from smaller cities, and launches its 'Value Plus' health plan.
Tier-2 and tier-3 health insurance penetration is currently growing at over twice the metro rate, supporting this geographic pivot.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.